Shell-vial assay: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii.
about
Q feverLaboratory maintenance of Rickettsia rickettsiiFrom Q Fever to Coxiella burnetii Infection: a Paradigm Change.Current and past strategies for bacterial culture in clinical microbiology.Q fever in the Greek island of Crete: detection, isolation, and molecular identification of eight strains of Coxiella burnetii from clinical samples.Correlation between ratio of serum doxycycline concentration to MIC and rapid decline of antibody levels during treatment of Q fever endocarditis.In vitro activities of telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, anUse of aminoglycosides in treatment of infections due to intracellular bacteriaDraft genome sequence of Coxiella burnetii Dog Utad, a strain isolated from a dog-related outbreak of Q fever.Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay.Sequence of quinolone resistance-determining region of gyrA gene for clinical isolates and for an in vitro-selected quinolone-resistant strain of Coxiella burnetiiEtiologies of illness among patients meeting integrated management of adolescent and adult illness district clinician manual criteria for severe infections in northern Tanzania: implications for empiric antimicrobial therapyA Q Fever Outbreak in the Netherlands: Consequences for Tissue Banking.Treatment of Q feverIn vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycinAntimicrobial therapies for Q fever.Coxiella burnetii blood cultures from acute and chronic Q-fever patients.Characterization of a Coxiella burnetii ftsZ mutant generated by Himar1 transposon mutagenesis.Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics.Bacteriostatic and bactericidal activities of moxifloxacin against Coxiella burnetii.In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin.In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin.Wolbachia pipientis growth kinetics and susceptibilities to 13 antibiotics determined by immunofluorescence staining and real-time PCR.In vitro activities of ceftriaxone and fusidic acid against 13 isolates of Coxiella burnetii, determined using the shell vial assay.Detection of Coxiella burnetti by DNA amplification using polymerase chain reaction.Susceptibility of Rickettsia conorii, R. rickettsii, and Coxiella burnetii to PD 127,391, PD 131,628, pefloxacin, ofloxacin, and ciprofloxacin.Azithromycin for acute Q fever in pregnancy.Comparison of Japanese isolates of Coxiella burnetii by PCR-RFLP and sequence analysis.In vitro susceptibility to tetracycline and fluoroquinolones of Japanese isolates of Coxiella burnetii.Treatment of atypical pneumonia with azithromycin: comparison of a 5-day and a 3-day course.Use of macrolides for Q fever.
P2860
Q24550722-C061A059-0105-47A9-9F0B-07D47C48826EQ24653341-6209353C-4A08-4F1F-B260-ACB6A6CD92C5Q30241105-6E81DC25-0E45-49F4-859A-9A0EF3D5FBC7Q30883196-50CEDFEA-6326-49BE-9EFC-DB3653CFDC17Q33673800-05F62706-7CBB-4BF1-B6A8-F6749DB94BA0Q33883633-938BB05B-AF4E-4F99-9B65-420A58A25160Q33979566-41828979-2FD4-41C8-9342-47BA99423EC9Q33983252-39990FA3-B72F-4D7F-8092-128420509FCEQ34286515-E40C40EF-A4D0-4DBD-B186-8857D11AF142Q34991405-CB7CA59C-25E2-4AA7-8A27-B137B5BBF64EQ35123601-C6AC09E2-E34C-4B37-B0E2-29A8EB548726Q35140509-4BC7E3AC-777F-48C8-AE5C-2474BD198F62Q35706578-0D5C3117-E34C-443A-9CB3-B1BB0FBC185DQ35818504-F70B68D7-95CC-423B-998C-4F4682115A45Q35904249-BE2EDB1A-AB80-4892-84A1-86CCA60E2C9AQ36169968-143E2683-9E77-4745-AA20-034FFDD8F891Q36526287-3363C1DD-F44E-4C75-A03E-CB082A0DB278Q37110501-9BAE4832-9F8F-4B23-986D-681922E4A246Q37204133-54164184-1A91-4261-808E-F0A8E7225E41Q39476051-88424C46-CEDF-4E63-B7CA-C78C94CCAFAFQ39479010-D901EEF7-1E11-45EB-BEED-ECBE4CDA8938Q39559260-00D8B51A-2221-4BD4-8E19-B2A205D2552CQ39746369-5B97DD62-A9C1-418B-9C29-65F9ABF8F238Q39865175-7A2D1DAA-086D-44EB-8988-68C4A62AD026Q40187555-F13AA2F0-9FE2-4A55-8852-CA17C7A6A375Q40284597-581BD8FB-6404-4A56-A0E6-9DE908F2C959Q40382974-76F898CB-4518-46EB-8C4B-1A04972B5878Q40518643-475F2043-30B2-4E96-8029-94052E134D4FQ40525310-457BD60C-6AC2-4307-B65A-8E22994D877CQ40639997-482B3CEE-087F-485E-AC9F-3E423A087E86Q42852779-2732883F-A58F-4972-AA85-EB8511DA0C7B
P2860
Shell-vial assay: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Shell-vial assay: evaluation o ...... isolates of Coxiella burnetii.
@ast
Shell-vial assay: evaluation o ...... isolates of Coxiella burnetii.
@en
type
label
Shell-vial assay: evaluation o ...... isolates of Coxiella burnetii.
@ast
Shell-vial assay: evaluation o ...... isolates of Coxiella burnetii.
@en
prefLabel
Shell-vial assay: evaluation o ...... isolates of Coxiella burnetii.
@ast
Shell-vial assay: evaluation o ...... isolates of Coxiella burnetii.
@en
P2860
P356
P1476
Shell-vial assay: evaluation o ...... isolates of Coxiella burnetii.
@en
P2093
P2860
P304
P356
10.1128/AAC.35.10.2070
P407
P577
1991-10-01T00:00:00Z